EU-PEARL is a strategic partnership between the public and private sectors formed in 2019 to shape the future of clinical trials. Under the umbrella of the Innovative Medicines Initiative, the Consortium developed a generic framework and a set of tools to conduct patient-centric collaborative platform trials, Integrated Research Platforms (IRPs). These will contribute to make clinical trials more efficient, potentially shortening the timeline to develop and bring to market new medicines for patients.

Learn more about collaborative platform trials in this video.

PROJECT RESULTS

The work done at EU-PEARL contributes to improve and accelerate medicine development processes by combining research efforts of many stakeholders. The 36 partners that conformed the EU-PEARL Consortium have the common goal of serving the patients in and outside of the trials, thus potentially enabling speedier access to new and more effective treatments.

Generic Tools and Resources

View and employ the innovative and generic trial design methodology and toolbox developed by EU-PEARL to conduct collaborative platform trials. Take advantage of the advanced real-world data management, protection and sharing guidelines and templates to facilitate the design and running of this type of trials.

Patient Engagement Resources

Patients and community representatives actively contributed to make EU-PEARLs framework for platform trials truly patient-centric. Use the Patient and Community Engagement Platform to see informational resources created and/or compiled by EU-PEARL to ensure that the factors that matter most to patients are embedded in the trial design.  

Disease Specific Resources

Discover templates, guidance documents and other resources to facilitate the design and set up of collaborative platform trials across four major disease areas, including major depressive disorder, tuberculosis, non-alcoholic steatohepatitis, and neurofibromatosis.

Generic Tools and Resources

View and employ the innovative and generic trial design methodology and toolbox developed by EU-PEARL to conduct collaborative platform trials. Take advantage of the advanced real-world data management, protection and sharing guidelines and templates to facilitate the design and running of this type of trials.

Patient Engagement

Patients and community representatives actively contributed to make EU-PEARLs framework for platform trials truly patient-centric. Use the Patient and Community Engagement Platform to see informational resources created and/or compiled by EU-PEARL to ensure that the factors that matter most to patients are embedded in the trial design.  

Disease Specific Resources

Discover templates, guidance documents and other resources to facilitate the design and set up of collaborative platform trials across four major disease areas, including major depressive disorder, tuberculosis, non-alcoholic steatohepatitis, and neurofibromatosis.

Can’t find a specific resource?

Search by keywords

Be part of the EU-PEARL
Community!

Experts and organisations that participated in EU-PEARL have come together in a vibrant community of practice. They have the critical knowledge, services and resources around IRPs to ensure that adaptive platform trials can thrive in future. 

 

Learn more

Watch this two-minute video and learn how platform trials are designed

Be part of the EU-PEARL
Community!

Experts and organisations that participated in EU-PEARL have come together in a vibrant community of practice. They have the critical knowledge, services and resources around IRPs to ensure that adaptive platform trials can thrive in future. 

Learn more

Watch this two-minute video and learn how platform trials are designed